HISUN: Plans to win the bid for national centralized drug procurement
HISUN announced that recently, the company and its wholly-owned subsidiary, Hanhui Pharmaceutical, participated in the bidding work for the 11th batch of national centralized drug procurement organized by the Joint Procurement Office. According to the "Public Announcement of Proposed Winning Results for National Centralized Drug Procurement" released by the Joint Procurement Office on October 28, 2025, the company and its wholly-owned subsidiary, Hanhui Pharmaceutical, are proposed to win the bid for 3 products that fall within the scope of this centralized procurement
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments